跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

CTI CLINICAL TRIAL AND CONSULTING SERVICES AUSTRALIA PTY LTD

首页临床试验发起方与机构CTI CLINICAL TRIAL AND CONSULTING SERVICES AUSTRALIA PTY LTD

CTI CLINICAL TRIAL AND CONSULTING SERVICES AUSTRALIA PTY LTD

LEVEL 16 80 COLLINS STREET SOUTH TOWER, Melbourne, Victoria, 澳大利亚

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

相关临床试验

7

1 进行中

药物批准

0

批准总数

监管机构

0

监管机构数

成立时间

N/A

概览

试验阶段分布

阶段

试验数

占比

1 期

7

100.0%

试验状态分布

已完成

6

85.7%

尚未招募

1

14.3%

相关临床试验

该机构主办的试验（7）

A Phase 1, Three-Part Open-Label Drug-Drug Interaction Study in Healthy participants to Determine the Effects of Itraconazole on the Pharmacokinetics of JNT-517 (Victim) and the Effects of JNT-517 (Perpetrator) on the Pharmacokinetics of Midazolam and Pravastati

Jun 202436 名受试者

First in human study of multiple doses of a novel drug PTC607 to assess its safety and tolerability in healthy participants

Dec 202324 名受试者

First in human clinical study of a novel drug PTC607 to assess effects of food intake and to compare PTC607 levels, when taken as an oral suspension and tablet formulation.

Mar 20238 名受试者

First in human clinical study of a novel drug PTC607 to assess its safety and tolerability in healthy volunteers

Dec 202240 名受试者

First in human clinical study of a novel drug JNT-517 to assess its safety and tolerability, effects of food intake and to compare JNT-517 levels when taken as an oral suspension and tablet formulation.

Sep 202212 名受试者

First in human clinical study of a novel drug JNT-517 to assess its safety and tolerability in healthy volunteers

Sep 202272 名受试者

INB03 for patients with metastatic cancer with increased inflammatory biomarkers in peripheral blood

Apr 201811 名受试者

药物批准

暂无批准数据

资讯

暂无资讯文章

本页目录

概览
相关临床试验7
药物批准
资讯

返回机构列表